Methodological concerns and a lack of evidence for reforming regulatory exclusivities for pharmaceuticals

Nature Biotechnology 2026

View at publisher
Authors: Kristina M. L. Acri
DOI: 10.1038/s41587-026-03165-6
Cited by: 1
References: 1

Fields of Study & Subjects

Biomedical Ethics and Regulation Pharmaceutical Economics and Policy Biosimilars and Bioanalytical Methods

Publication details

Journal / source
Nature Biotechnology
Publisher
Springer Science and Business Media LLC
Volume
44
Issue
6
Pages
893–894
Publication date
1 June 2026
Language
EN